DÉTECTION DE MOLÉCULES DÉRIVÉES DU GLX
- 专利权人:
- GLX Analytix ApS
- 发明人:
- 申请号：
- EP18194086.7
- 公开号：
- EP3623816A1
- 申请日:
- 2018.09.12
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to biomarkers associated with immune-mediated inflammatory disease (IMID), particular GLX molecules, and even more particular GLX-related glycosaminglycans (GAGs) and GLX-related proteoglycans (PGs).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Biomarkers for determining clinical response to cell therapy
- NOUVELLES MOLÉCULES IMMUNOTHÉRAPEUTIQUES ET UTILISATIONS ASSOCIÉES
- BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY
- Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorder
- pyridin-2 (1h) -one derivatives useful as medicines for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
